Protein-based nanoparticles for therapeutic nucleic acid delivery

Biomaterials. 2024 Jan 2;305:122464. doi: 10.1016/j.biomaterials.2023.122464. Online ahead of print.ABSTRACTTo realize the full potential of emerging nucleic acid therapies, there is a need for effective delivery agents to transport cargo to cells of interest. Protein materials exhibit several unique properties, including biodegradability, biocompatibility, ease of functionalization via recombinant and chemical modifications, among other features, which establish a promising basis for therapeutic nucleic acid delivery systems. In this review, we highlight progress made in the use of non-viral protein-based nanoparticles for nucleic acid delivery in vitro and in vivo, while elaborating on key physicochemical properties that have enabled the use of these materials for nanoparticle formulation and drug delivery. To conclude, we comment on the prospects and unresolved challenges associated with the translation of protein-based nucleic acid delivery systems for therapeutic applications.PMID:38181574 | DOI:10.1016/j.biomaterials.2023.122464
Source: Biomaterials - Category: Materials Science Authors: Source Type: research